It was hypothesised that genetic modification of viruses to encode for an extracellular matrix degrading enzyme would improve virus spread through solid tumours. Initially, the effect of extracellular matrix degrading enzymes on adenovirus infection was investigated in 3-dimensional spheroid cell cultures. Hyaluronidase demonstrated good enhancement of adenovirus infection with limited toxicity and was therefore investigated further. The oncolytic adenovirus, vKH6, was modified to encode the sperm-associated hyaluronidase SP AMi, however no hyaluronidase activity was detectable from infected cells. A replication-deficient adenovirus encoding SP AMi was also engineered and found to produce hyaluronidase activity. A vaccinia virus with attenu...
Oncolytic adenoviruses (Ad) that selectively replicate in cancer cells are emerging as a promising n...
Adenoviruses (Ads) have been extensively manipulated for the development of cancer selective replica...
Current shortcomings in cancer therapy require the generation of new, broadly applicable, potent, ta...
Genetically attenuated viruses are under development as selectively replicating antitumoral agents. ...
Oncolytic viruses which infect and kill tumour cells can also be genetically modified to express the...
Oncolytic viruses which infect and kill tumour cells can also be genetically modified to express the...
Adenovirus serotype 5 (Ad5) is widely used as an oncolytic agent for cancer therapy. However, its in...
[eng] The oncolytic viruses (OVs) preferentially infect tumor and selectively replicate in cancer ce...
Oncolytic adenoviruses (Ads) have been shown to be safe and have great potential for the treatment o...
The use of adenoviruses for gene transfer and as oncolytic agents is currently receiving widespread ...
Abstract The research described in this thesis focused on generating more effective adenovirus an...
Oncolytic viruses (OVs) preferentially infect and selectively replicate in cancer cells. OVs have be...
Oncolytic adenovirus (Ad) holds great promise as a potential gene therapy for cancer. However, intra...
The use of oncolytic viruses for the treatment of cancer is an emerging field of cancer research and...
Recombinant viral vectors hold great promise in the field of cancer gene therapy. While a plethora o...
Oncolytic adenoviruses (Ad) that selectively replicate in cancer cells are emerging as a promising n...
Adenoviruses (Ads) have been extensively manipulated for the development of cancer selective replica...
Current shortcomings in cancer therapy require the generation of new, broadly applicable, potent, ta...
Genetically attenuated viruses are under development as selectively replicating antitumoral agents. ...
Oncolytic viruses which infect and kill tumour cells can also be genetically modified to express the...
Oncolytic viruses which infect and kill tumour cells can also be genetically modified to express the...
Adenovirus serotype 5 (Ad5) is widely used as an oncolytic agent for cancer therapy. However, its in...
[eng] The oncolytic viruses (OVs) preferentially infect tumor and selectively replicate in cancer ce...
Oncolytic adenoviruses (Ads) have been shown to be safe and have great potential for the treatment o...
The use of adenoviruses for gene transfer and as oncolytic agents is currently receiving widespread ...
Abstract The research described in this thesis focused on generating more effective adenovirus an...
Oncolytic viruses (OVs) preferentially infect and selectively replicate in cancer cells. OVs have be...
Oncolytic adenovirus (Ad) holds great promise as a potential gene therapy for cancer. However, intra...
The use of oncolytic viruses for the treatment of cancer is an emerging field of cancer research and...
Recombinant viral vectors hold great promise in the field of cancer gene therapy. While a plethora o...
Oncolytic adenoviruses (Ad) that selectively replicate in cancer cells are emerging as a promising n...
Adenoviruses (Ads) have been extensively manipulated for the development of cancer selective replica...
Current shortcomings in cancer therapy require the generation of new, broadly applicable, potent, ta...